Free Trial

Enovix (NASDAQ:ENVX) COO Sells $1,441,200.00 in Stock

Enovix logo with Energy background

Key Points

  • Enovix COO Ajay Marathe sold 120,000 shares for approximately $1.44 million, reducing his ownership by 10.46% to over 1 million shares.
  • Enovix's stock price increased by 8.7%, reaching $12.96, following strong trading volume significantly above its average.
  • The company reported revenue of $7.50 million for the previous quarter, marking a 98.2% year-over-year increase despite a negative EPS of -$0.13.
  • Five stocks to consider instead of Enovix.

Enovix Corporation (NASDAQ:ENVX - Get Free Report) COO Ajay Marathe sold 120,000 shares of Enovix stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $12.01, for a total transaction of $1,441,200.00. Following the transaction, the chief operating officer directly owned 1,027,259 shares in the company, valued at $12,337,380.59. This represents a 10.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Enovix Stock Up 8.7%

ENVX stock traded up $1.04 during trading on Monday, reaching $12.96. The stock had a trading volume of 10,020,100 shares, compared to its average volume of 6,759,230. Enovix Corporation has a one year low of $5.27 and a one year high of $16.49. The company has a quick ratio of 4.11, a current ratio of 4.37 and a debt-to-equity ratio of 0.82. The company's 50 day moving average is $10.42 and its two-hundred day moving average is $9.34. The company has a market capitalization of $2.55 billion, a price-to-earnings ratio of -15.43 and a beta of 2.07.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 73.88% and a negative net margin of 481.35%.The firm had revenue of $7.50 million for the quarter, compared to the consensus estimate of $5.48 million. During the same quarter in the previous year, the business earned ($0.14) EPS. The company's revenue was up 98.2% compared to the same quarter last year. Enovix has set its Q3 2025 guidance at -0.180--0.140 EPS. Equities research analysts forecast that Enovix Corporation will post -1.01 EPS for the current year.

Enovix declared that its board has approved a stock repurchase plan on Wednesday, July 2nd that permits the company to repurchase $60.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its shares are undervalued.

Hedge Funds Weigh In On Enovix

A number of hedge funds have recently modified their holdings of ENVX. Moody National Bank Trust Division increased its holdings in Enovix by 34.8% during the 3rd quarter. Moody National Bank Trust Division now owns 100,775 shares of the company's stock valued at $1,005,000 after purchasing an additional 25,995 shares during the period. Reynders McVeigh Capital Management LLC increased its holdings in Enovix by 11.1% during the 2nd quarter. Reynders McVeigh Capital Management LLC now owns 260,330 shares of the company's stock valued at $2,692,000 after purchasing an additional 26,090 shares during the period. Promus Capital LLC increased its stake in shares of Enovix by 3,500.0% during the second quarter. Promus Capital LLC now owns 18,000 shares of the company's stock valued at $186,000 after buying an additional 17,500 shares during the period. B. Riley Wealth Advisors Inc. purchased a new position in shares of Enovix during the second quarter valued at approximately $290,000. Finally, Headlands Technologies LLC purchased a new position in shares of Enovix during the second quarter valued at approximately $132,000. Hedge funds and other institutional investors own 50.92% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ENVX shares. Benchmark upped their price objective on Enovix from $15.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, July 25th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Enovix in a research report on Saturday, September 27th. TD Cowen raised shares of Enovix to a "hold" rating and upped their price objective for the company from $7.00 to $15.00 in a report on Monday, July 7th. B. Riley reaffirmed a "buy" rating and set a $17.00 price objective (up from $12.00) on shares of Enovix in a report on Thursday, July 10th. Finally, Canaccord Genuity Group upped their price target on shares of Enovix from $20.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $17.00.

Check Out Our Latest Stock Analysis on ENVX

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.